1
Mod-06 Lec-22 Regulation of gene expression by type II nuclear receptors
Mod-06 Lec-22 Regulation of gene expression by type II nuclear receptors
DATE: 2011/09/27::
2
Farnesoid Receptor X
Farnesoid Receptor X
DATE: 2015/02/05::
3
Charité Clinical Journal Club by Fred Luft - 18.3.2015
Charité Clinical Journal Club by Fred Luft - 18.3.2015
DATE: 2015/03/26::
4
The interplay of Natural Products, Nutrition, Diabetes, Obesity and the nuclear receptor PPARgamma
The interplay of Natural Products, Nutrition, Diabetes, Obesity and the nuclear receptor PPARgamma
DATE: 2014/12/15::
5
Mannkind Corporation Is In Good Hands
Mannkind Corporation Is In Good Hands
DATE: 2014/07/09::
6
The 4th Week of August
The 4th Week of August's Notable Recap: MannKind, InterMune, and Natural Health Trends Corp.
DATE: 2014/08/29::
7
Mannkind Shareholders Stop Your Weekend Worrying
Mannkind Shareholders Stop Your Weekend Worrying
DATE: 2014/06/22::
8
In Alfred Mann We Trust
In Alfred Mann We Trust
DATE: 2014/07/13::
9
I Hate Boring Medical Classes, But Treasure Moments Like This
I Hate Boring Medical Classes, But Treasure Moments Like This
DATE: 2015/02/09::
10
Part 1 of MannKind and Intercept Presentation
Part 1 of MannKind and Intercept Presentation
DATE: 2014/12/30::
11
廣鼎雷光獵狐光學電競滑鼠 FXR-SM-03 玩具開箱文
廣鼎雷光獵狐光學電競滑鼠 FXR-SM-03 玩具開箱文
DATE: 2013/09/12::
12
The MD-360 Report: Updates on Catalyst Keys for MannKind Afrezza Launch
The MD-360 Report: Updates on Catalyst Keys for MannKind Afrezza Launch
DATE: 2015/03/15::
13
Can USEC Stocks Defy Earth Gravity After Its Recent Trip To The Moon
Can USEC Stocks Defy Earth Gravity After Its Recent Trip To The Moon
DATE: 2014/07/07::
14
The FXR LIVES AGAIN!
The FXR LIVES AGAIN!
DATE: 2014/08/04::
15
The 360 Biotech Show With Doctor Tran
The 360 Biotech Show With Doctor Tran
DATE: 2014/06/20::
16
Sir John Templeton and Peter Lynch
Sir John Templeton and Peter Lynch
DATE: 2015/02/15::
17
2014-Recap and 2015-Outlook for MannKind Corporation and Intercept Pharmaceuticals
2014-Recap and 2015-Outlook for MannKind Corporation and Intercept Pharmaceuticals
DATE: 2015/01/03::
18
The Sanofi-MannKind Partnership Afrezza
The Sanofi-MannKind Partnership Afrezza
DATE: 2015/02/04::
19
PetSmart To Benefit From Activist Shareholders, JANA Partners
PetSmart To Benefit From Activist Shareholders, JANA Partners
DATE: 2014/07/07::
20
360 Biotech: Mannkind Shareholders Stop Your  Weekend Worrying Post Afrezza Approval!
360 Biotech: Mannkind Shareholders Stop Your Weekend Worrying Post Afrezza Approval!
DATE: 2014/06/29::
21
360 Biotech Commentary On Mannkind Revolutionary Research
360 Biotech Commentary On Mannkind Revolutionary Research
DATE: 2014/06/26::
22
360 Biotech The State of Mannkind
360 Biotech The State of Mannkind
DATE: 2014/07/04::
23
Why the Sanofi Partnership is Favorable for MannKind
Why the Sanofi Partnership is Favorable for MannKind
DATE: 2014/08/28::
NEXT >>
RESULTS [24 .. 74]
From Wikipedia, the free encyclopedia
Jump to: navigation, search
Nuclear receptor subfamily 1, group H, member 4
Protein NR1H4 PDB 1osh.png
PDB rendering based on 1osh.
Available structures
PDB Ortholog search: PDBe, RCSB
Identifiers
Symbols NR1H4 ; BAR; FXR; HRR-1; HRR1; RIP14
External IDs OMIM603826 MGI1352464 HomoloGene3760 IUPHAR: NR1H4 ChEMBL: 2047 GeneCards: NR1H4 Gene
RNA expression pattern
PBB GE NR1H4 206340 at tn.png
More reference expression data
Orthologs
Species Human Mouse
Entrez 9971 20186
Ensembl ENSG00000012504 ENSMUSG00000047638
UniProt Q96RI1 Q60641
RefSeq (mRNA) NM_001206977 NM_001163504
RefSeq (protein) NP_001193906 NP_001156976
Location (UCSC) Chr 12:
100.87 – 100.96 Mb
Chr 10:
89.45 – 89.53 Mb
PubMed search [1] [2]

The bile acid receptor (BAR), also known as farnesoid X receptor (FXR) or NR1H4 (nuclear receptor subfamily 1, group H, member 4) is a nuclear receptor that is encoded by the NR1H4 gene in humans.[1][2]

Function[edit]

FXR is expressed at high levels in the liver and intestine. Chenodeoxycholic acid and other bile acids are natural ligands for FXR. Similar to other nuclear receptors, when activated, FXR translocates to the cell nucleus, forms a dimer (in this case a heterodimer with RXR) and binds to hormone response elements on DNA, which up- or down-regulates the expression of certain genes.[2]

One of the primary functions of FXR activation is the suppression of cholesterol 7 alpha-hydroxylase (CYP7A1), the rate-limiting enzyme in bile acid synthesis from cholesterol. FXR does not directly bind to the CYP7A1 promoter. Rather, FXR induces expression of small heterodimer partner (SHP), which then functions to inhibit transcription of the CYP7A1 gene. In this way a negative feedback pathway is established in which synthesis of bile acids is inhibited when cellular levels are already high. FXR has also been found to be important in regulation of hepatic triglyceride levels.[3]

Interactions[edit]

Farnesoid X receptor has been shown to interact with:

Ligands[edit]

A number of ligands for FXR are known, of both natural and synthetic origin.[6][7][8]

Agonists
Antagonists

References[edit]

  1. ^ "Entrez Gene: NR1H4 nuclear receptor subfamily 1, group H, member 4". 
  2. ^ a b Forman BM, Goode E, Chen J, Oro AE, Bradley DJ, Perlmann T et al. (June 1995). "Identification of a nuclear receptor that is activated by farnesol metabolites". Cell 81 (5): 687–93. doi:10.1016/0092-8674(95)90530-8. PMID 7774010. 
  3. ^ Jiao Y, Lu Y, Li X (2015). "Farnesoid X receptor: a master regulator of hepatic triglyceride and glucose homeostasis". Acta Pharmacol. Sin. 36 (1): 44–50. doi:10.1038/aps.2014.116. PMID 25500875. 
  4. ^ Zhang Y, Castellani LW, Sinal CJ, Gonzalez FJ, Edwards PA (January 2004). "Peroxisome proliferator-activated receptor-gamma coactivator 1alpha (PGC-1alpha) regulates triglyceride metabolism by activation of the nuclear receptor FXR". Genes Dev. 18 (2): 157–69. doi:10.1101/gad.1138104. PMC 324422. PMID 14729567. 
  5. ^ Seol W, Choi HS, Moore DD (January 1995). "Isolation of proteins that interact specifically with the retinoid X receptor: two novel orphan receptors". Mol. Endocrinol. 9 (1): 72–85. doi:10.1210/mend.9.1.7760852. PMID 7760852. 
  6. ^ Fiorucci S, Zampella A, Distrutti E (2012). "Development of FXR, PXR and CAR agonists and antagonists for treatment of liver disorders". Curr Top Med Chem 12 (6): 605–24. doi:10.2174/156802612799436678. PMID 22242859. 
  7. ^ Fiorucci S, Mencarelli A, Distrutti E, Zampella A (2012). "Farnesoid X receptor: from medicinal chemistry to clinical applications". Future Med Chem 4 (7): 877–91. doi:10.4155/fmc.12.41. PMID 22571613. 
  8. ^ Vaz B, de Lera ÁR (2012). "Advances in drug design with RXR modulators". Expert Opin Drug Discov 7 (11): 1003–16. doi:10.1517/17460441.2012.722992. PMID 22954251.  Vancouver style error (help)

Further reading[edit]

External links[edit]


Wikipedia content is licensed under the GFDL License
Powered by YouTube
MASHPEDIA
LEGAL
  • Mashpedia © 2015